Terry Vance is Director at ENANTA PHARMACEUTICALS INC (ENTA). They have made 3 open-market trades across 1 company since 2013, most recently 2023-12-13.
CIK 0001572282
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $240K since 2013, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENTA | 5,800 | $62K |
Shares reported on the most recent Form 4, priced at the 2023-12-15 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.